Rapport Therapeutics closes private placement of 1,058,824 shares at $17.00 per share with existing stockholders

Rapport Therapeutics, Inc.

Entered Stock Purchase Agreements with Sofinnova Venture Partners and affiliates of Goldman Sachs for 1,058,824 shares at $17.00/share, concurrent with IPO.
Private placement closed June 10, 2024; placement agents included Goldman Sachs, Jefferies, TD Securities, and Stifel.
Shares issued under Section 4(a)(2) exemption to institutional accredited investors; Sofinnova granted registration rights after one-year anniversary.
Filed third amended and restated certificate of incorporation and bylaws in connection with IPO effectiveness.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.